Novartis Aktie
136,44
EUR
+0,42
EUR
+0,31
%
136,98
EUR
+0,56
EUR
+0,41
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 26.01.12 | Novartis underperform | Cheuvreux SA | |
| 29.11.11 | Novartis underperform | Cheuvreux SA | |
| 25.11.09 | Novartis underperform | Cheuvreux SA | |
| 12.11.09 | Novartis underweight | Barclays Capital | |
| 18.09.08 | Novartis underperform | Cheuvreux SA | |
| 09.09.08 | Novartis underperform | Cheuvreux SA | |
| 16.07.08 | Novartis underperform | Credit Suisse Group | |
| 16.01.08 | Novartis underperform | Credit Suisse Group | |
|
Werbung
|
|||
| 18.07.07 | Novartis underperform | Crédit Suisse | |
| 19.01.06 | Novartis reduzieren | Independent Research | |
| 21.07.05 | Novartis Net Negative | Susquehanna Financial | |
| 17.06.05 | Novartis reduce | UBS | |
| 19.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 11.01.05 | Novartis Sell | Banc of America Sec. | |
Werbung
Werbung